Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Anavex Life Sciences Corp. (AVXL) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-9.83M |
|
-- |
|
-- |
|
$10.84M |
|
$-10.84M |
|
$1.02M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-10.84M |
|
$-10.84M |
|
85.29M |
|
85.29M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$103.81M |
|
-- |
|
-- |
|
$103.81M |
|
$8.95M |
|
-- |
|
-- |
|
$8.95M |
|
$94.87M |
|
$94.87M |
|
$94.87M |
|
86.67M |
|
| Cash Flow Statement Financials | |
$-39.04M |
|
-- |
|
$9.43M |
|
$132.19M |
|
$102.58M |
|
$-29.61M |
|
$11.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.60 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-39.04M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.36% |
|
-10.36% |
|
-9.47% |
|
-10.36% |
|
$1.09 |
|
$-0.46 |
|
$-0.46 |
|